Summary: Over a period of 16 years There were 7 deaths, three unrelated to liver disease. Survival analysis gives an 86% 5-year survival and 56% 10-year survival. Twenty four patients were treated with steroids (and 6 additionally with azathioprine); 15 (63%) were steroid responsive and 9 were non-responsive. In five patients steroids were successfully discontinued but in 10 patients severe symptomatic relapse occurred on steroid reduction below 7.5-10 mg/day. Steroid non-responders were not typical CAH, 5 with predominantly a rise in alkaline phosphatase, one multisystem disease and one HBV positive. Steroid discontinuation was only possible in one third of the patients responding. Eighteen subjects (69%) were cirrhotic at initial biopsy; 9 had follow-up biopsies, 6 were unchanged but three had progressed to cirrhosis despite apparent steroid responsiveness.
Introduction
Published studies on chronic active hepatitis (CAH) have come from large referral centre. '-5 Although the crucial studies at the start ofthe last decade defined the condition and established appropriate treatment regimes, certain aspects of the condition, as seen in a non-referral centre, have not been emphasized despite increasing knowledge of the pathogenesis of CAH. [5] [6] [7] [8] The present study establishes the incidence of the condition in a defined population, assesses changes in the pattern of inci' -nce, measures long-term prognosis and tre, lient outcome, and categorizes the aetioloey in ilis non-referral population. Figure 1 . The incidence of CAH is approximately 1:100,000/year and has remained unchanged over this time period (6-7 cases in the District every 5 years). In all except 6 subjects presentation was with an acute hepatitic illness and initial transaminase measurement was > 500 IU/I in 19 subjects. In most ,o6
.0 E 4. patients a prodrome of malaise and weight loss over a number of months preceded the presentation at hospital.
Investigations relating to aetiology are shown in Table I Twenty four subjects were treated with steroids (30-60 mg prednisolone daily) and, of these, 15 were steroid responsive using clinical and biochemical criteria, although 6 required the addition of azathio- 
